Sonitus Medical, Inc., a San Mateo, CA-based medical device, has closed a $25m Series D venture capital funding.
The round was led by Abingworth, with participation from all current investors.
The company intends to use the funding to expand its marketing efforts for the SoundBite system in the US.
Founded in June 2006 and led by CEO Amir Abolfathi, Sonitus Medical manufactures a non-surgical and removable hearing device to transmit sound via the teeth. It has already received FDA 510(k) clearance for two indications, single sided deafness and conductive hearing loss.
In conjunction with fhe funding, David Mayer, Partner at Abingworth, has joined the company’s Board of Directors.